SRA1 Monoclonal Antibody

Both long non-coding and protein-coding RNAs are transcribed from this gene, and they represent alternatively spliced transcript variants. This gene was initially defined as a non-coding RNA, which is a coactivator for several nuclear receptors (NRs) and is associated with breast cancer. It has now been found that this gene is involved in the regulation of many NR and non-NR activities, including metabolism, adipogenesis and chromatin organization. The long non-coding RNA transcripts interact with a variety of proteins, including the protein encoded by this gene. The encoded protein acts as a transcriptional repressor by binding to the non-coding RNA.

Introducing the SRA1 Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of immunology. This meticulously crafted antibody is the result of extensive research and development, harnessing the power of monoclonal technology to provide unparalleled specificity and sensitivity in antibody-based assays.

The SRA1 Monoclonal Antibody boasts a high affinity for its target antigen, ensuring precise and accurate detection. Its exceptional specificity enables the discrimination of even closely related antigens, facilitating the identification and characterization of specific biomarkers with utmost confidence.

With an optimized formulation, this antibody exhibits exceptional stability and reproducibility, guaranteeing consistent and reliable results across experiments. Its robust performance is further enhanced by its compatibility with a wide range of applications, including immunohistochemistry, flow cytometry, and Western blotting, making it an indispensable tool for researchers across various disciplines.

Furthermore, the SRA1 Monoclonal Antibody is manufactured under stringent quality control measures, adhering to the highest industry standards. Each batch undergoes rigorous testing to ensure batch-to-batch consistency, purity, and functionality, providing researchers with the utmost assurance in experimental reproducibility.

In addition to its exceptional performance, this antibody is also available in various formats and sizes, catering to diverse experimental requirements. Whether in a liquid or lyophilized form, the SRA1 Monoclonal Antibody offers flexibility and convenience, allowing for easy integration into existing laboratory protocols.

In summary, the SRA1 Monoclonal Antibody represents a breakthrough in immunological research, offering unrivaled specificity, sensitivity, and versatility. With its exceptional performance and stringent quality control, this antibody is poised to elevate scientific investigations and accelerate discoveries in the realm of immunology. Embrace the future of antibody-based assays with the SRA1 Monoclonal Antibody and unlock new frontiers in your research endeavors.